FILE PHOTO: A health official draws a dose of the AstraZeneca's COVID-19 vaccine manufactured by the Serum Institute of India, at Infectious Diseases Hospital in Colombo, Sri Lanka January 29, 2021. REUTERS/Dinuka Liyanawatte//File Photo
NEW DELHI (Reuters) - India could resume deliveries of COVID-19 shots to global vaccine-sharing platform COVAX in a few weeks for the first time since April, two health industry sources said, ending a suspension of supplies that has hurt poor countries.
The World Health Organization (WHO), which co-leads COVAX, has been urging India to restart supplies for the programme, especially after it sent about 4 million doses to its neighbours and partners in October.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
